Overcoming of multidrug resistance by VA-033, a novel derivative of apovincaminic acid ester

European Journal of Pharmacology

Volumn 327, Issue 2-3, 1997, Pages 239-246

  Nanaumi, Kayoko ^a   Tsuchida, Katsuharu ^a   Nakaike, Shiro ^a   Yamagishi, Takehiro ^a   Ichihara, Tomoko ^a   Takahashi, Kenzo ^a   Watajima, Hiroshi ^a   Suzuki, Yasuhito ^a   Naito, Mikihiko ^b   Tsuruo, Takashi ^b  

^a TAISHO PHARMACEUTICAL CO LTD   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Ca2+ current; Chemotherapeutic; P glycoprotein; Verapamil

Indexed keywords

APOVINCAMINIC ACID; AZIDOPINE; DOXORUBICIN; GLYCOPROTEIN P; UNCLASSIFIED DRUG; VA 033; VERAPAMIL; VINCRISTINE;

ARTICLE; CALCIUM CURRENT; CANCER RESISTANCE; CARDIOVASCULAR PARAMETERS; DOG; DRUG EFFECT; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; SURVIVAL TIME; TUMOR CELL;

EID: 16744363513     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)89667-7     Document Type: Article

References (24)

1. Akiyama S., Fojo A., Hanover J.A., Pastan I., Gottesman M.M. Isolation and genetic characterization of human KB cell lines resistant to multiple drugs. Somat. Cell Mol. Genet. 11:1985;117-126.
2. Akiyama S., Cornwell M.M., Kuwano M., Pastan I., Gottesman M.M. Most drugs that reverse multidrug resistance also inhibit photoaffinity labeling of P-glycoprotein by a vinblastine analogue. Mol. Pharmacol. 33:1988;144-147.
3. Beck W.T. Mechanisms of multidrug resistance in human tumor cells; the role of P-glycoprotein, DNA topoisomerase 2 and other factors. Cancer Treat. Rev. 17:1990;11-20.
4. Biedler J.L., Riehm H. Cellular resistance to actinomycin D in Chinese hamster cells in vitro: cross-resistance, radioautographic and cytogenetic studies. Cancer Res. 30:1970;1174-1184.
5. Borchers C., Ulrich W.-R., Klemm K., Ise W., Gekeler V., Haas S., Schodl A., Conrad J., Pryzybylski M., Boer R. B9209-005, an azido derivative of the chemosensitizer dexniguldipine-HCl, photolabels P-glycoprotein. Mol. Pharmacol. 48:1995;21-29.
6. Bradford M.A. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal. Biochem. 72:1976;248-254.
7. Carmichael J., DeGraff W.G., Gazdar A.F., Minna J.D., Mitchell J.B. Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res. 47:1987;943-946.
8. Chen C.-j., Chin J.E., Ueda K., Clark D.P., Pastan I., Gottesman M.M., Roninson I.B. Internal duplication and homology with bacterial transport proteins in the mdr 1 (P-glycoprotein) gene from multidrug-resistant human cells. Cell. 47:1986;381-389.
9. Cornwell M.M., Pastan I., Gottesman M.M. Certain calcium channel blockers bind specifically to multidrug-resistant human KB carcinoma membrane vesicle and inhibit drug binding to P-glycoprotein. J. Biol. Chem. 262:1987;2166-2170.
10. Dalton W.S., Grogan T.M., Meltzer P.S., Sheper R.J., Durie B.G., Taylor C.W., Miller T.P., Salmon S.E. Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy. J. Clin. Oncol. 7:1989;415-424.
11. Ferry D.R., Russell M.A., Cullen M.H. P-glycoprotein possesses a 1,4-dihydropyridine-selective drug acceptor site which is allosterically coupled to a vinca-alkaloid-selective binding site. Biochem. Biophys. Res. Commun. 188:1992;440-445.
12. Fleckenstein A. History of calcium antagonist. Circ. Res. 52:1983;I3-I16.
13. Gerlach J.H., Endicott J.A., Juranka P.F., Henderson G., Sarangi F., Deuchars K., Ling V. Homology between P-glycoprotein and a bacterial haemolysin transport protein suggests a model for multidrug resistance. Nature. 324:1986;485-489.
14. Gros P., Croop J., Housman D. Mammalian multidrug-resistance gene: complete cDNA sequence indicates strong homology to bacterial transport proteins. Cell. 47:1986;371-380.
15. Hamada H., Tsuruo T. Purification of the 170- to 180-kilodalton membrane glycoprotein associated with multidrug resistance. J. Biol. Chem. 263:1988;1454-1458.
16. Inaba M., Fujikura R., Tsukagoshi S., Sakurai Y. Restored in vitro sensitivity of adriamycin and vincristine-resistant P388 leukemia with reserpine. Biochem. Pharmacol. 30:1981;2191-2194.
17. Kameyama M., Hofmann F., Trautwein W. On the mechanisms of beta-adrenergic regulation of the Ca channel in the guinea-pig heart. Pflüg. Arch. 405:1985;285-293.
18. 3H]azidopine photolabeling of P-glycoprotein by newly synthesized dihydropyridine analogues in a human cell line. Cancer Res. 49:1989;3190-3195.
19. Lever J.E. Active amino acid transport in plasma membrane vesicles from simian virus 40-transformed mouse fibroblasts. J. Biol. Chem. 252:1977;1990-1997.
20. Niwa K., Yamada K., Furukawa T., Shudo N., Seto K., Matsumoto T., Takao S., Akiyama S., Shimazu H. Effect of a dihydropyridine analogue, 2-[benzyl(phenyl)amino]ethyl 1,4-dihydro-2,6-dimethyl-5-(5,5-dimethyl-2-oxo-1,3,2-dioxaphosphorinan-2-yl)-1- (2-morpholino-ethl)-4-(3-nitrophenyl)-3 pyridinecarboxylate on reversing in vivo resistance of tumor cells to adriamycin. Cancer Res. 52:1992;3655-3660.
21. Safa A.R., Glover C.J., Sewell J.L., Meyers M.B., Biedler J.L., Felsted R.L. Identification of the multidrug resistance-related membrane glycoprotein as an acceptor for calcium channel blocker. J. Biol. Chem. 262:1987;7884-7888.
22. Tsuchida K., Watajima H., Otomo S. Calcium current in rat diabetic ventricular myocytes. Am. J. Physiol. 367:1994;H2280-H2289.
23. Tsuruo T., Iida H., Tsukagoshi S., Sakurai Y. Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil. Cancer Res. 41:1981;1967-1972.
24. Tsuruo T., Iida H., Kitatani Y., Yokota K., Tsukagoshi S., Sakurai Y. Effects of quinidine and related compounds on cytotoxicity and cellular accumulation of vincristine and adriamycin in drug-resistant tumor cells. Cancer Res. 44:1984;4303-4307.